Murideoxycholic Acid

Description: Murideoxycholic Acid alleviates non-alcoholic fatty liver disease by modulating the enterohepatic axis. Target: Endogenous Metabolite. Smiles: [H][C@@]12CC[C@H]([C@H](C)CCC(O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])C[C@@H](O)[C@]2([H])C[C@H](O)CC[C@]12C. References: Khallou J, et al. Metabolism and time-course excretion of murideoxycholic acid, a 6 beta-hydroxylated bile acid, in humans. J Hepatol. 1993,17(3):364-372.